|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-10-2
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To assess the effects of 24-week treatment with vildagliptin on measures of beta-cell function in a broad spectrum of drug-naïve patients with type 2 diabetes (T2DM).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adamantane,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/C-Peptide,
http://linkedlifedata.com/resource/pubmed/chemical/Dipeptidyl-Peptidase IV Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Nitriles,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidines,
http://linkedlifedata.com/resource/pubmed/chemical/vildagliptin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1463-1326
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
931-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18093207-Adamantane,
pubmed-meshheading:18093207-Aged,
pubmed-meshheading:18093207-Biological Markers,
pubmed-meshheading:18093207-Blood Glucose,
pubmed-meshheading:18093207-C-Peptide,
pubmed-meshheading:18093207-Clinical Trials, Phase III as Topic,
pubmed-meshheading:18093207-Diabetes Mellitus, Type 2,
pubmed-meshheading:18093207-Dipeptidyl-Peptidase IV Inhibitors,
pubmed-meshheading:18093207-Female,
pubmed-meshheading:18093207-Hemoglobin A, Glycosylated,
pubmed-meshheading:18093207-Humans,
pubmed-meshheading:18093207-Hypoglycemic Agents,
pubmed-meshheading:18093207-Insulin,
pubmed-meshheading:18093207-Insulin-Secreting Cells,
pubmed-meshheading:18093207-Male,
pubmed-meshheading:18093207-Middle Aged,
pubmed-meshheading:18093207-Multicenter Studies as Topic,
pubmed-meshheading:18093207-Nitriles,
pubmed-meshheading:18093207-Pyrrolidines
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database.
|
|
pubmed:affiliation |
University of Vermont College of Medicine, Burlington, VT, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
